Breaking News

WCG Acquires eClinical Provider VeraSci

Aims to address growing demand for scientific and technology solutions for remote data capture, hybrid virtual studies and decentralized clinical trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WCG has acquired VeraSci, a global provider of specialty scientific expertise and eClinical software to support clinical trials focused on central nervous system (CNS) disorders. VeraSci, based in Durham, NC, expands WCG’s scientific and patient engagement capabilities, and complements its CNS offerings, including those available via the Company’s MedAvante, ProPhase and Analgesic Solutions businesses. With this acquisition, WCG aims to address the growing demand for scientific and t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters